Nicholas Flytzanis

About

Nicholas Flytzanis, Ph.D., is a co-founder of Capsida Biotherapeutics and currently serves as its Chief Research and Innovation Officer. He previously served as scientific director of the CLOVER research center at the California Institute of Technology, where he led interdisciplinary work spanning neurological research and gene therapy. His scientific background centers on AAV engineering, gene therapy, tissue clearing and imaging, and optogenetics.

Areas of interest